Royalty Pharma Plc (RPRX)
40.21
-0.15
(-0.37%)
USD |
NASDAQ |
Jan 14, 16:00
40.22
+0.02
(+0.04%)
After-Hours: 20:00
Royalty Pharma Market Cap: 17.18B for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Denali Therapeutics, Inc. | 2.853B |
| Alnylam Pharmaceuticals, Inc. | 48.47B |
| Amgen, Inc. | 177.14B |
| PTC Therapeutics, Inc. | 6.205B |
| Zenas BioPharma, Inc. | 943.78M |
Market Cap Related Metrics
| PE Ratio | 22.99 |
| PS Ratio | 9.791 |
| Price to Book Value | 2.678 |
| Price to Free Cash Flow | 21.95 |
| Price | 40.21 |
| Earnings Yield | 4.35% |
| Operating PE Ratio | 15.02 |
| Normalized PE Ratio | 21.89 |